Members

Name: Massimo

Surname: Breccia

Academic title: Associate Professor MD

Charge: Head of Day Hospital Unit and Myeloid disorders unit

Which is your area of expertise for the "Disease/group of diseases"?

• Diagnostics
• Treatment and care

Specify your expertise for the "Disease/group of diseases" (eg SCT, Molecular diagnosis):

Diagnostic classification, treatment and follow-up of patients affected by myeloproliferative disorders (CML and Ph negative diseases) treated with tyrosine kinase inhibitors, management of toxicity. Diagnosis and management of acute promyelocytic leukemia. Management of patients enrolled in experimental trials (including phase 1a). Diagnosis of MDS (low and high risk) and AML and management.

Disease groups:

Acquired idiopathic sideroblastic anemia Acute myeloid leukemia (AML) Acute promyelocytic leukemia Chronic myeloid leukemia Hypereosinophilic syndrome Myelodysplastic syndrome Myelodysplastic/myeloproliferative disease Myeloid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB or FGFR0 Myeloid neoplasms with germline predisposition or inherited Myeloproliferative neoplasm (Other than Chronic myeloid leukemia and Primary myelofibrosis) Rare thrombotic disorder due to quantitative platelet anomaly (High)

Which is your patient age coverage?

• Adults
• Ageing

Member Substitute

Webinars:

• Clonal hypereosinophilic conditions: Chronic eosinophilic leukemia (CEL) + L-HES
• Clonal hypereosinophilic conditions: Myeloid/lymphoid disorders with eosinophilia and tyrosine kinase (TK) fusion genes